Fusion Pharmaceuticals Inc (FUSN.O)

+ 收藏

资产负债表(Fusion Pharmaceuticals Inc)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报
截止日期 2024-03-312023-12-312023-09-302023-06-302023-03-31
报表类型 合并报表合并报表合并报表合并报表合并报表
报表年结日 12311231123112311231
原始币种 美元美元美元美元美元
上市前/上市后 上市后上市后上市后上市后上市后
流动资产:
 现金及现金等价物(元) 会员可见会员可见会员可见会员可见53,617,000.00
 受限制存款及现金流动(元) 会员可见会员可见会员可见会员可见419,000.00
 应收账款及票据(元) -会员可见会员可见会员可见89,000.00
 预付款项及其他应收款流动(元) 会员可见会员可见会员可见会员可见10,272,000.00
 短期投资(元) 会员可见会员可见会员可见会员可见156,227,000.00
 流动资产合计(元) 会员可见会员可见会员可见会员可见220,624,000.00
非流动资产:
 物业、厂房及设备(元) 会员可见会员可见会员可见会员可见5,141,000.00
 受限制存款及现金非流动(元) 会员可见会员可见会员可见会员可见849,000.00
 递延所得税资产非流动(元) 会员可见会员可见会员可见会员可见5,300,000.00
 长期投资(元) 会员可见会员可见会员可见会员可见11,338,000.00
 非流动资产其他项目(元) 会员可见会员可见会员可见会员可见23,299,000.00
 非流动资产合计(元) 会员可见会员可见会员可见会员可见45,927,000.00
总资产(元) 会员可见会员可见会员可见会员可见266,551,000.00
流动负债:
 融资租赁负债流动(元) 会员可见会员可见会员可见会员可见4,638,000.00
 应付账款及票据(元) 会员可见会员可见会员可见会员可见1,904,000.00
 应付税项流动(元) ----97,000.00
 其他应付款及应计费用(元) 会员可见会员可见会员可见会员可见10,353,000.00
 递延收入流动(元) 会员可见会员可见会员可见会员可见333,000.00
 流动负债合计(元) 会员可见会员可见会员可见会员可见17,325,000.00
非流动负债:
 长期债务(元) 会员可见会员可见会员可见会员可见34,360,000.00
 融资租赁负债非流动(元) 会员可见会员可见会员可见会员可见11,067,000.00
 应付税项非流动(元) 会员可见会员可见会员可见会员可见299,000.00
 递延收入非流动(元) 会员可见会员可见会员可见会员可见2,667,000.00
 非流动负债合计(元) 会员可见会员可见会员可见会员可见48,393,000.00
总负债(元) 会员可见会员可见会员可见会员可见65,718,000.00
股东权益:
 股本溢价(元) 会员可见会员可见会员可见会员可见507,071,000.00
 留存收益(元) 会员可见会员可见会员可见会员可见-306,153,000.00
 累计其他全面收益(元) 会员可见会员可见会员可见会员可见-85,000.00
 归属于母公司股东权益(元) 会员可见会员可见会员可见会员可见200,833,000.00
 股东权益合计(元) 会员可见会员可见会员可见会员可见200,833,000.00
负债及股东权益合计(元) 会员可见会员可见会员可见会员可见266,551,000.00
公告日期 2024-05-072024-03-202023-11-072023-08-082023-05-11
会计准则 美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则
审计意见
核数师

前瞻产业研究院